companydata.dkcompanydata.dk

NEUROLOGISK KLINIK ApS: Financial statements 2017

CVR: 31748429

Source: annual report 2017, Danish Business Authority

01/01/2017 – 31/12/2017

NEUROLOGISK KLINIK ApS (CVR 31748429) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 201,725 and a net result of DKK 100,395 compared with DKK 29,752 the year before. That is an increase of 80.8% compared with the year before. Equity in the 2017 report amounted to DKK 362,797. The solvency ratio was 53.7%.

Gross Profit
DKK 201,725
Profit/Loss
DKK 100,395
Equity
DKK 362,797
Total Assets
DKK 675,501
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2017-202K100K363K0
2016-112K30K262K-
2015-157K63K233K-
2014308K262K192K419K-
2013326K-251K228K-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on NEUROLOGISK KLINIK ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2017

NEUROLOGISK KLINIK ApS: The 2016 annual report is outJun 5, 2017

NEUROLOGISK KLINIK ApS has published its annual report for 2016. Gross profit came to DKK 111,583, and the net result was DKK 29,752.

About NEUROLOGISK KLINIK ApS

NEUROLOGISK KLINIK ApS was a Danish company of the type Anpartsselskab based in Langå, founded in 2008. The company has been dissolved on 19 December 2023. The company was registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named SOMNOLEPSION BIOTECH ApS. The company has 0 employees (2020). In 2022, the company reported a gross profit of DKK 99,955 and a net result of DKK 265,911 compared with DKK 699,794 the year before. Equity in the 2022 report amounted to DKK 1,716,091.

Source: annual report 2022, Danish Business Authority